Terms: = Prostate cancer AND CUX1, ENSG00000160967, P39880, p75, p200, p110, p100, Nbla10317, CUX, COY1, CDP, CASP, 1523 AND Treatment
45 results:
1. Combination of navitoclax (Bcl-2 and Bcl-xL inhibitor) and Debio-0932 (Hsp90 inhibitor) suppresses the viability of prostate cancer cells via induction of apoptotic signaling pathway.
Asdemir A; Özgür A
Med Oncol; 2024 Mar; 41(4):83. PubMed ID: 38436810
[TBL] [Abstract] [Full Text] [Related]
2. treatment burden in individuals living with and beyond cancer: A systematic review of qualitative literature.
Adam R; Nair R; Duncan LF; Yeoh E; Chan J; Vilenskaya V; Gallacher KI
PLoS One; 2023; 18(5):e0286308. PubMed ID: 37228101
[TBL] [Abstract] [Full Text] [Related]
3. Extended therapy with [
Mader N; Nguyen Ngoc C; Kirkgöze B; Baumgarten J; Groener D; Klimek K; Happel C; Tselis N; Chun FKH; Grünwald F; Sabet A
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1811-1821. PubMed ID: 36702927
[TBL] [Abstract] [Full Text] [Related]
4. Azithromycin and Ceftriaxone Differentially Activate NLRP3 in LPS Primed cancer Cells.
Tezcan G; Alsaadi M; Hamza S; Garanina EE; Martynova EV; Ziganshina GR; Farukshina ER; Rizvanov AA; Khaiboullina SF
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012769
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of the Anticancer Potential of Crude, Irradiated
Abdelglil MI; Abdallah SO; El-Desouky MA; Alfaifi MY; Elbehairi SEI; Mohamed AF
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834153
[TBL] [Abstract] [Full Text] [Related]
6. Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer.
Li S; Wu R; Wang L; Dina Kuo HC; Sargsyan D; Zheng X; Wang Y; Su X; Kong AN
Mol Carcinog; 2022 Jan; 61(1):111-121. PubMed ID: 34727410
[TBL] [Abstract] [Full Text] [Related]
7. The LEDGF/p75 Integrase Binding Domain Interactome Contributes to the Survival, Clonogenicity, and Tumorsphere Formation of Docetaxel-Resistant prostate cancer Cells.
Ortiz-Hernandez GL; Sanchez-Hernandez ES; Ochoa PT; Elix CC; Alkashgari HR; McMullen JRW; Soto U; Martinez SR; Diaz Osterman CJ; Mahler M; Roy S; Casiano CA
Cells; 2021 Oct; 10(10):. PubMed ID: 34685704
[TBL] [Abstract] [Full Text] [Related]
8. First-in-human, phase I/IIa study of CRLX301, a nanoparticle drug conjugate containing docetaxel, in patients with advanced or metastatic solid malignancies.
Piha-Paul SA; Thein KZ; De Souza P; Kefford R; Gangadhar T; Smith C; Schuster S; Zamboni WC; Dees CE; Markman B
Invest New Drugs; 2021 Aug; 39(4):1047-1056. PubMed ID: 33594602
[TBL] [Abstract] [Full Text] [Related]
9. Oral Administration of the p75 Neurotrophin Receptor Modulator, LM11A-31, Improves Erectile Function in a Mouse Model of Cavernous Nerve Injury.
Yin GN; Ock J; Limanjaya A; Minh NN; Hong SS; Yang T; Longo FM; Ryu JK; Suh JK
J Sex Med; 2021 Jan; 18(1):17-28. PubMed ID: 33243690
[TBL] [Abstract] [Full Text] [Related]
10. p110δ PI3K as a therapeutic target of solid tumours.
Xenou L; Papakonstanti EA
Clin Sci (Lond); 2020 Jun; 134(12):1377-1397. PubMed ID: 32556179
[TBL] [Abstract] [Full Text] [Related]
11. FOXA1 knock-out via CRISPR/Cas9 altered casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.
Albayrak G; Konac E; Ugras Dikmen A; Bilen CY
Exp Biol Med (Maywood); 2018 Aug; 243(12):990-994. PubMed ID: 30043639
[TBL] [Abstract] [Full Text] [Related]
12. Cumulative incidence and predictive factors of radiation cystitis in patients with localized prostate cancer.
Afonso-João D; Pacheco-Figueiredo L; Antunes-Lopes T; Morgado LA; Azevedo V; Vendeira L; Silva J; Martins-Silva C
Actas Urol Esp (Engl Ed); 2018 May; 42(4):256-261. PubMed ID: 29169704
[TBL] [Abstract] [Full Text] [Related]
13. Association Between Radiation Therapy, Surgery, or Observation for Localized prostate cancer and Patient-Reported Outcomes After 3 Years.
Barocas DA; Alvarez J; Resnick MJ; Koyama T; Hoffman KE; Tyson MD; Conwill R; McCollum D; Cooperberg MR; Goodman M; Greenfield S; Hamilton AS; Hashibe M; Kaplan SH; Paddock LE; Stroup AM; Wu XC; Penson DF
JAMA; 2017 Mar; 317(11):1126-1140. PubMed ID: 28324093
[TBL] [Abstract] [Full Text] [Related]
14. Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes.
Ríos-Colón L; Cajigas-Du Ross CK; Basu A; Elix C; Alicea-Polanco I; Sanchez TW; Radhakrishnan V; Chen CS; Casiano CA
Oncotarget; 2017 Apr; 8(15):24915-24931. PubMed ID: 28212536
[TBL] [Abstract] [Full Text] [Related]
15. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in prostate and Breast cancer Cells with the Z-FY-CHO Inhibitor.
Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
[TBL] [Abstract] [Full Text] [Related]
16. Efficacy of synbiotics to reduce acute radiation proctitis symptoms and improve quality of life: a randomized, double-blind, placebo-controlled pilot trial.
Nascimento M; Aguilar-Nascimento JE; Caporossi C; Castro-Barcellos HM; Motta RT
Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):289-95. PubMed ID: 25304789
[TBL] [Abstract] [Full Text] [Related]
17. Prediction model for penile prosthesis implantation for erectile dysfunction management.
Segal RL; Camper SB; Ma L; Burnett AL
Curr Med Res Opin; 2014 Oct; 30(10):2131-7. PubMed ID: 24945719
[TBL] [Abstract] [Full Text] [Related]
18. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract] [Full Text] [Related]
19. Morbidity of focal therapy in the treatment of localized prostate cancer.
Barret E; Ahallal Y; Sanchez-Salas R; Galiano M; Cosset JM; Validire P; Macek P; Durand M; Prapotnich D; Rozet F; Cathelineau X
Eur Urol; 2013 Apr; 63(4):618-22. PubMed ID: 23265382
[TBL] [Abstract] [Full Text] [Related]
20. Butein induces apoptosis and inhibits prostate tumor growth in vitro and in vivo.
Khan N; Adhami VM; Afaq F; Mukhtar H
Antioxid Redox Signal; 2012 Jun; 16(11):1195-204. PubMed ID: 22114764
[TBL] [Abstract] [Full Text] [Related]
[Next]
